Iradimed Co (IRMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Iradimed Co (IRMD) has a cash flow conversion efficiency ratio of 0.058x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.94 Million) by net assets ($101.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Iradimed Co stock valuation for the company's overall valuation and market capitalisation.
Iradimed Co - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Iradimed Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Iradimed Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Iradimed Co ranked by their cash flow conversion efficiency. Explore cash flow quality index of Iradimed Co to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Foosung
KO:093370
|
-0.023x |
|
Droneshield Ltd
AU:DRO
|
-0.013x |
|
Jupiter Wagons Limited
NSE:JWL
|
-0.041x |
|
Bellring Brands LLC
NYSE:BRBR
|
-0.170x |
|
Inrom Construction Industries Ltd
TA:INRM
|
0.023x |
|
Sansteel MinGuang Co Ltd Fujian
SHE:002110
|
0.114x |
|
Arendals Fossekompani ASA
OL:AFK
|
0.013x |
|
I.E.S Holdings Ltd
TA:IES
|
0.006x |
Annual Cash Flow Conversion Efficiency for Iradimed Co (2012–2025)
The table below shows the annual cash flow conversion efficiency of Iradimed Co from 2012 to 2025. View Iradimed Co share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $94.62 Million | $24.95 Million | 0.264x | -10.67% |
| 2024-12-31 | $86.82 Million | $25.62 Million | 0.295x | +56.55% |
| 2023-12-31 | $71.42 Million | $13.47 Million | 0.189x | +38.31% |
| 2022-12-31 | $73.67 Million | $10.04 Million | 0.136x | -12.61% |
| 2021-12-31 | $72.17 Million | $11.26 Million | 0.156x | +64.59% |
| 2020-12-31 | $61.38 Million | $5.82 Million | 0.095x | -48.58% |
| 2019-12-31 | $55.52 Million | $10.23 Million | 0.184x | +4.80% |
| 2018-12-31 | $41.95 Million | $7.38 Million | 0.176x | +69.52% |
| 2017-12-31 | $32.93 Million | $3.42 Million | 0.104x | -64.83% |
| 2016-12-31 | $31.89 Million | $9.41 Million | 0.295x | +23.14% |
| 2015-12-31 | $31.93 Million | $7.65 Million | 0.240x | +93.53% |
| 2014-12-31 | $20.89 Million | $2.59 Million | 0.124x | -54.48% |
| 2013-12-31 | $5.42 Million | $1.47 Million | 0.272x | -41.98% |
| 2012-12-31 | $3.22 Million | $1.51 Million | 0.469x | -- |
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs moni… Read more